These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24337061)

  • 21. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
    Xu GY; Tang XJ
    Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The impact of decreased Stat3 activation on 5-fluorouracil resistance of human gastric cancer cell line].
    Yu LF; Chen Y; Qiao MM; Zhang YP; Wu YL
    Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):903-6. PubMed ID: 15730734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
    Lee HW; Kim SJ; Choi IJ; Song J; Chun KH
    Clin Exp Metastasis; 2015 Aug; 32(6):593-603. PubMed ID: 26134677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TWEAK and Fn14: new molecular targets for cancer therapy?
    Winkles JA; Tran NL; Berens ME
    Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
    Zhu C; Zhang L; Liu Z; Li C; Bai Y
    J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells.
    Zhu Y; Yu J; Wang S; Lu R; Wu J; Jiang B
    Oncol Rep; 2014 Dec; 32(6):2437-44. PubMed ID: 25230779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
    Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
    Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells.
    Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M
    Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.
    Voboril R; Hochwald SN; Li J; Brank A; Weberova J; Wessels F; Moldawer LL; Camp ER; MacKay SL
    J Surg Res; 2004 Aug; 120(2):178-88. PubMed ID: 15234211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
    Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
    Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells.
    Zhang H; Tang J; Li C; Kong J; Wang J; Wu Y; Xu E; Lai M
    Cancer Lett; 2015 Jan; 356(2 Pt B):781-90. PubMed ID: 25449431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.
    Girgenrath M; Weng S; Kostek CA; Browning B; Wang M; Brown SA; Winkles JA; Michaelson JS; Allaire N; Schneider P; Scott ML; Hsu YM; Yagita H; Flavell RA; Miller JB; Burkly LC; Zheng TS
    EMBO J; 2006 Dec; 25(24):5826-39. PubMed ID: 17124496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
    Shui Y; Guan ZB; Zhang SQ
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction.
    Benicchi T; Iozzi S; Svahn A; Axelsson H; Mori E; Bernocco S; Cappelli F; Caramelli C; Fanti P; Genesio E; Maccari L; Markova N; Micco I; Porcari V; Schultz J; Fecke W
    J Biomol Screen; 2012 Aug; 17(7):933-45. PubMed ID: 22644269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.